Wang Julia Aijun — SEC Form 4 filings
SEC reporting owner CIK 1860279. 11 Form 4 filings on record with FilingPulse; latest filed 2026-02-13.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-03-04 to 2026-02-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 2,684 shares, $419,865 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 899 shares @ $155.66 ($139,938) in BeiGene, Ltd., filed 2024-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BeiGene, Ltd. (BGNE) | Chief Financial Officer | 5 | — | 7 legs · 2,684 sh · $419,865 | 2 |
| LABCORP HOLDINGS INC. (LH) | Chief Financial Officer, EVP | 6 | — | — | 15 |
Form 4 filings — Wang Julia Aijun
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 860 · Tax withholding (F): 245 @ $289.89 · Option exercise (M): 860 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 7,100 (derivative) @ $0 · Grant/award (A): 2,350 (derivative) @ $0 | EDGAR |
| 2026-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 893 · Tax withholding (F): 254 @ $277.20 · Option exercise (M): 893 (derivative) @ $0 | EDGAR |
| 2025-02-13 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 7,800 (derivative) @ $0 · Grant/award (A): 2,580 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | LABCORP HOLDINGS INC. (LH) | Option exercise (M): 893 · Tax withholding (F): 336 @ $247.74 · Option exercise (M): 893 (derivative) @ $0 | EDGAR |
| 2024-12-04 | 4 | LABCORP HOLDINGS INC. (LH) | Grant/award (A): 8,100 (derivative) @ $0 · Grant/award (A): 2,680 (derivative) @ $0 | EDGAR |
| 2024-07-03 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 472 @ $143.90 | EDGAR |
| 2024-06-26 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 899 @ $155.66 | EDGAR |
| 2024-06-20 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 154 @ $158.24 · Sale (S): 195 @ $158.58 · Sale (S): 253 @ $159.00 · Sale (S): 314 @ $159.74 | EDGAR |
| 2024-06-07 | 4 | BeiGene, Ltd. (BGNE) | Grant/award (A): 136,240 @ $0 · Grant/award (A): 256,659 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | BeiGene, Ltd. (BGNE) | Sale (S): 397 @ $167.08 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1860279 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →